Transactions
Ventyx Biosciences, Inc.’s sale to Eli Lilly and Company
Date Announced:
01/07/2025
client:
Ventyx Biosciences, Inc.
Status:
Pending
Value:
$1.2 billion
Date Announced:
01/07/2025
client:
Ventyx Biosciences, Inc.
Status:
Pending
Value:
$1.2 billion
